| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |